Fidelity® Equity Dividend Income K (FETKX)
26.71
+0.77 (+2.97%)
USD |
Jun 24 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.49% | 5.949B | 2.36% | 47.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -402.08M | 1.17% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks reasonable income; capital appreciation is a secondary consideration. The fund normally invests at least 80% of assets in equity securities. It normally invests primarily in income-producing equity securities that pay current dividends and show potential for capital appreciation, which tends to lead to investments in large cap "value" stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FEQTX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Equity-Income |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Russell 3000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| John Sheehy | 5.15 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
87
-402.08M
-5.417B
Category Low
19.57B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2022
Performance Versus Category
As of June 24, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of June 24, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Bristol-Myers Squibb Co | 3.40% | 78.96 | 1.63% |
| Unilever PLC ADR | 3.06% | 46.25 | 3.77% |
| Verizon Communications Inc | 2.93% | 50.96 | -2.17% |
| Johnson & Johnson | 2.81% | 182.29 | 1.46% |
| Amdocs Ltd | 2.46% | 84.88 | 4.20% |
|
Fidelity Revere Str Tr
|
2.46% | -- | -- |
| Merck & Co Inc | 2.22% | 93.13 | 1.23% |
| Sanofi SA ADR | 2.19% | 53.42 | 5.95% |
| Wells Fargo & Co | 2.03% | 40.76 | 7.55% |
| Cisco Systems Inc | 1.88% | 44.10 | 2.73% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | Upgrade |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
Basic Info
| Investment Strategy | |
| The investment seeks reasonable income; capital appreciation is a secondary consideration. The fund normally invests at least 80% of assets in equity securities. It normally invests primarily in income-producing equity securities that pay current dividends and show potential for capital appreciation, which tends to lead to investments in large cap "value" stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FEQTX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Equity-Income |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Russell 3000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| John Sheehy | 5.15 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (6-24-22) | 2.36% |
| 30-Day SEC Yield (5-31-22) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 14.98 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of April 30, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 5/9/2008 |
| Last Annual Report Date | 11/30/2021 |
| Last Prospectus Date | 1/29/2022 |
| Share Classes | |
| FEQTX | No Load |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |